• Mashup Score: 0

    Background: Safety of whole-lung low-dose radiation therapy (LD-RT) for COVID-19 pneumonia has been established in two phase I trials. By focally dampening pulmonary cytokine hyperactivation, LD-RT may improve outcomes in hospitalized and oxygen-dependent COVID-19 patients. Methods: Patients with COVID-19 pneumonia were treated with 1.5 Gy whole-lung LD-RT, followed for 28 days or at least until…

    Tweet Tweets with this article
    • Nice article on a pilot trial of #LowDoseRadiation for severe #COVID19 patients out of @emoryhealthcare. Will need to follow up with a randomized trial with confirmatory data, but this is an interesting start. First inspired by work from the #1918flu. https://t.co/XBzFoJopK4